These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Research ethics and revised law regarding the Danish Central Scientific Ethical Committee]. Kamper-Jørgensen F Ugeskr Laeger; 2004 Jun; 166(24):2337-40. PubMed ID: 15281571 [No Abstract] [Full Text] [Related]
43. [Legal liability in drug trials]. Frölich JC Z Arztl Fortbild (Jena); 1995 Nov; 89(6):641-6. PubMed ID: 8588438 [TBL] [Abstract][Full Text] [Related]
44. [Critique of compulsory responsibilities of insured persons in endangerment according to the therapeutic drug law]. Rittner C; Schaper J; Wessler I Versicherungsmedizin; 1996 Feb; 48(1):21-3. PubMed ID: 8852074 [TBL] [Abstract][Full Text] [Related]
46. Inspection of clinical investigations by the German health authorities. Schmidt M Methods Find Exp Clin Pharmacol; 1993 May; 15(4):229-31. PubMed ID: 8361260 [TBL] [Abstract][Full Text] [Related]
47. [Clinical trials of drugs in university hospitals. Legal aspects]. Lippert HD Dtsch Med Wochenschr; 1993 Mar; 118(10):355-8. PubMed ID: 8453904 [No Abstract] [Full Text] [Related]
48. Informed consent: an ethics question. Frelick RW Del Med J; 1988 Sep; 60(9):523-5. PubMed ID: 3181549 [No Abstract] [Full Text] [Related]
49. Medical research on humans: regulation in Switzerland, the European Union, and the United States. Schott M Food Drug Law J; 2005; 60(1):45-77. PubMed ID: 15940854 [No Abstract] [Full Text] [Related]
50. [Responsibility for patient education in drug therapy from the viewpoint of the drug industry]. Lerch C Z Arztl Fortbild (Jena); 1994 Dec; 88(12):1055-60. PubMed ID: 7716982 [No Abstract] [Full Text] [Related]
51. [Tasks and meaning of the ethics commission]. Jahrmärker H Med Klin (Munich); 1990 Nov; 85(11):672-8. PubMed ID: 2266918 [No Abstract] [Full Text] [Related]
53. [Ethical principles for clinical studies with minors. Medical progress only for adults?]. Koch HJ; Raschka C MMW Fortschr Med; 2002 Sep; 144(38):51. PubMed ID: 12395705 [No Abstract] [Full Text] [Related]
54. [Medical research in children: the pros and cons of extending the legal boundaries]. Visser HK Ned Tijdschr Geneeskd; 2010; 154():A2395. PubMed ID: 20858300 [TBL] [Abstract][Full Text] [Related]
55. [Ethics and clinical drug trials]. Villeneuve A Encephale; 1990; 16(4):281-2. PubMed ID: 2209483 [TBL] [Abstract][Full Text] [Related]
56. [Ethical and legal aspects of including patients unable to consent in acute therapy studies. Example of a medication study for the treatment of intracerebral hemorrhage--the Heidelberg procedure]. Steiner T; Walter-Sack I; Taupitz J; Hacke W; Strowitzki T Dtsch Med Wochenschr; 2008 Apr; 133(15):787-92. PubMed ID: 18382954 [TBL] [Abstract][Full Text] [Related]
57. Trials and errors: barriers to oversight of research conducted under the emergency research consent waiver. Kipnis K; King NM; Nelson RM IRB; 2006; 28(2):16-9. PubMed ID: 16770884 [No Abstract] [Full Text] [Related]
58. [Biomedical research: to know the judicial and legal aspects]. Malavaud B Prog Urol; 1994 Apr; 4(2):181-4. PubMed ID: 8199625 [TBL] [Abstract][Full Text] [Related]
59. [Clinical trials in children--between the expectations of scientific requirements, the assurance of proven treatment and ethical demands]. Lehmann B; Mentzer D; Fischer T; Mallinckrodt-Pape K Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):410-6. PubMed ID: 19266173 [TBL] [Abstract][Full Text] [Related]
60. [The system of scientific ethical committees]. Larsen NA Ugeskr Laeger; 2003 Jun; 165(23):2412-3. PubMed ID: 12841005 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]